Five things for pharma marketers to know: Monday, October 30, 2023

Five things for pharma marketers to know:

• Food and Drug Administration advisers plan to request additional studies for the Vertex Pharmaceuticals/CRISPR Therapeutics sickle cell disease gene therapy exa-cel.

• Pharmacy employees at Walgreens, CVS and other retail pharmacy chains have reached a “breaking point” as they cope with increasing workloads and burnout.

• A quarter of U.S. wastewater testing sites are currently shut down due to a conflict between the Centers for Disease Control and Prevention and Massachusetts-based firm Biobot.

• After 41 states launched a lawsuit against Meta for fueling social media addiction among children, experts explained the science behind the claims.

• The FDA approved Eli Lilly’s ulcerative colitis drug Omvoh, just six months after the agency rejected it over manufacturing issues.